Aprea Therapeutics
APRE
APRE
28 hedge funds and large institutions have $8.48M invested in Aprea Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
21% less capital invested
Capital invested by funds: $10.8M → $8.48M (-$2.29M)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$558K | |
| 2 | +$558K | |
| 3 | +$558K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.9K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$45.1K |
Top Sellers
| 1 | -$1.08K | |
| 2 | -$814 | |
| 3 | -$669 | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$570 |
| 5 |
OPTFSNA
Old Point Trust & Financial Services N A
Newport News,
Virginia
|
-$335 |